ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05231	Choline metabolism in cancer	3/23	134/7206	0.00848209516236
ko04145	Phagosome	3/23	162/7206	0.0141977292556
ko04140	Autophagy - animal	3/23	164/7206	0.0146725194699
ko05213	Endometrial cancer	2/23	62/7206	0.0164073783629
ko05221	Acute myeloid leukemia	2/23	63/7206	0.0169126809355
ko05223	Non-small cell lung cancer	2/23	66/7206	0.0184682574602
ko04072	Phospholipase D signaling pathway	3/23	197/7206	0.0238256299012
ko04370	VEGF signaling pathway	2/23	77/7206	0.0246645782404
ko04664	Fc epsilon RI signaling pathway	2/23	77/7206	0.0246645782404
ko05214	Glioma	2/23	79/7206	0.025871413827
ko04721	Synaptic vesicle cycle	2/23	80/7206	0.0264837993547
ko05230	Central carbon metabolism in cancer	2/23	81/7206	0.0271021090812
ko04137	Mitophagy - animal	2/23	82/7206	0.0277263025131
ko05218	Melanoma	2/23	85/7206	0.029633782772
ko05220	Chronic myeloid leukemia	2/23	85/7206	0.029633782772
ko04213	Longevity regulating pathway - multiple species	2/23	86/7206	0.0302811096423
ko04917	Prolactin signaling pathway	2/23	87/7206	0.0309341204107
ko00072	Synthesis and degradation of ketone bodies	1/23	10/7206	0.0314826730734
ko04662	B cell receptor signaling pathway	2/23	88/7206	0.0315927756434
ko05211	Renal cell carcinoma	2/23	96/7206	0.0370605434894
ko01521	EGFR tyrosine kinase inhibitor resistance	2/23	106/7206	0.0443698505101
ko04012	ErbB signaling pathway	2/23	109/7206	0.0466603973944
ko05215	Prostate cancer	2/23	111/7206	0.0482115883047
ko04070	Phosphatidylinositol signaling system	2/23	112/7206	0.0489943249222